NEW YORK, May 22, 2020 /PRNewswire/ -- The global antiviral
drugs market is expected to reach US$70.95
billion in 2024, increasing at a CAGR of 2.10%, for the
duration of 2020-2024. The factors such as, increasing prevalence
of HIV infections, upswing in international tourism, growth in
geriatric population, increasing pharmaceutical R&D spending,
rapid urbanization, upsurge in healthcare spending and growing
awareness about various viral diseases are expected to drive the
growth of the market. However, the market growth would be
challenged by high cost involves in drug development, threats
associated with drug counterfeiting and stringent government
regulations. A few notable trends may include accelerating growth
rate of infectious diseases, increasing focus on telehealth, growth
in pharmaceutical Merger & acquisitions and emergence of new
infectious diseases.
Read the full report:
https://www.reportlinker.com/p05896999/?utm_source=PRN
The global antiviral drugs market is fragmented into branded
drugs and generic drugs. Branded drugs dominate the market owing to
the increased levels of trust and reliability associated with
branded pharmaceutical companies among customers. However, generic
drugs are also gaining widespread popularity among customers due to
the low cost factor, which is likely to raise its share in global
market in coming years.
The fastest growing regional market was North America owing to the presence of key
players in the region, availability of sophisticated healthcare
infrastructure and increasing awareness of viral diseases among
people. Whereas, Europe and
Asia Pacific also contributed to
significant shares in the global market due to the factors such as
increase in patient pool of various infectious diseases and rise in
the acceptance of generic drugs. However, the sudden outbreak of
COVID-19 has caused a major disruption all across the world, which
is leading to the massive demand for antiviral drugs for the
management of infected coronavirus patients, providing the growth
opportunity to the market globally.
Scope of the report:
The report provides a comprehensive analysis of the global
antiviral drugs market.
The major regional markets (North
America, Europe,
Asia-Pacific Middle East & Africa) have been analyzed.
The market dynamics such as growth drivers, market trends and
challenges are analyzed in-depth.
The competitive landscape of the market, along with the company
profiles of leading players (Johnson & Johnson, Merck &
Co., AbbVie Inc., Bristol-Myer Squibb, Gilead Sciences and Cipla)
are also presented in detail.
Key Target Audience:
Antiviral Drugs Manufacturers
Pharmaceuticals and Biopharmaceutical Firms
End Users (Hospitals, Clinics, Pharmacies, Drugs Stores, etc.)
Investment Banks
Healthcare and Medical Consultants
Government Bodies & Regulating Authorities
Read the full report:
https://www.reportlinker.com/p05896999/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original
content:http://www.prnewswire.com/news-releases/global-antiviral-drugs-market-by-type-application--region-insights--forecast-with-potential-impact-of-covid-19-2020-2024-301064559.html
SOURCE Reportlinker